Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout-Reference-Cited by-同舟云学术

Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout

Published:2018-05-16 Issue:2 Volume:68 Page:449-461
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Huang Annsa C.¹^ORCID,Mehta Neil¹,Dodge Jennifer L.²,Yao Francis Y.¹²,Terrault Norah A.¹²

Affiliation:

1. Department of Medicine, Division of Gastroenterology/Hepatology; University of California San Francisco; San Francisco CA

2. Department of Surgery; University of California San Francisco; San Francisco CA

Funder

Liver Center, University of California, San Francisco

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29855/fullpdf

Reference39 articles.

1. Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis;Foster;J Hepatol,2016

2. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial;Manns;Lancet Infect Dis,2016

3. Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence;Poordad;Hepatology,2016

4. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;Meer;JAMA,2012

5. A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C;Backus;Clin Gastroenterol Hepatol,2011

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

2. Hepatocellular carcinoma after direct‐acting antivirals for hepatitis C is associated with KIR‐HLA types predicting weak NK cell‐mediated immunity;European Journal of Immunology;2024-05-03

4. Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation;Hepatology International;2024-02-28

5. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01